Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BJOG ; 118(7): 790-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21401856

ABSTRACT

BACKGROUND: Although several papers report on pregnancy and multiple sclerosis (MS), no systematic review of the literature has been carried out. Neurologists and obstetricians need to have proper information to discuss with women presenting with MS who consider pregnancy. OBJECTIVES: Literature review and meta-analysis of data on pregnancy in women with MS. SEARCH STRATEGY: The present work followed the recommendations of the PRISMA Statement. Using the PICO framework, the authors independently searched for the terms 'pregnancy' OR 'gestation' OR 'pregnant' AND 'multiple sclerosis' OR 'MS' in the following databases: EMBASE/Excerpta Medica, Medline, Pubmed, Scopus, Index Medicus, Biomed Central, Ebsco Fulltext, LILACS, Scielo and the Cochrane Database of Systematic Reviews. SELECTION CRITERIA: only papers presenting original work with analysis of at least one of the outcomes among pregnant women with MS were included. DATA COLLECTION AND ANALYSIS: Two independent workers performed the literature review. All the authors selected and read the relevant papers. Two other authors summarised data for analysis. MAIN RESULTS: Twenty-two papers reporting on 13,144 women with MS and their pregnancies were analysed. A significant decrease in relapse rate was observed during pregnancy, followed by a significant increase after delivery. Miscarriages, low birthweight, prematurity, neonatal death and malformations were assessed among these women and their offspring. There seems to be a regional influence on the rates of caesarean sections and abortions among women with MS. Neonatal death and malformation rates did not seem to be particularly high. AUTHORS' CONCLUSIONS: The present work provides evidence-based data that can be discussed with women with MS and their relatives when pregnancy is considered by these families.


Subject(s)
Multiple Sclerosis/epidemiology , Pregnancy Complications/epidemiology , Abortion, Spontaneous/epidemiology , Abortion, Spontaneous/etiology , Cesarean Section/statistics & numerical data , Female , Global Health , Humans , Infant, Low Birth Weight , Infant, Newborn , Infant, Premature , Multiple Sclerosis/complications , Pregnancy , Prevalence , Recurrence , Risk Assessment , Risk Factors
2.
Clin Neurol Neurosurg ; 113(4): 277-80, 2011 May.
Article in English | MEDLINE | ID: mdl-21159421

ABSTRACT

OBJECTIVES: To report the results from the Brazilian database on multiple sclerosis (MS) and pregnancy. METHODS: Retrospective data from MS patients who became pregnant at any time of their disease were sent to a Brazilian database, using a specific file for this purpose. RESULTS: Data on 128 women (142 pregnancies) from 30 neurologists working in 21 cities in Brazil were collected. Patients' average age at pregnancy was 29.8 years (range 16-42). EDSS at start of pregnancy was 1.5±1.4; and the relapse rate in the year preceding pregnancy was 1.2±1.5. Exposure to medication at any time during pregnancy was high (69.7%): 48.6% to interferon beta; 14.1% to glatiramer acetate; and 7% to other immunomodulatory and immunosuppressive drugs. There was a significant decrease in relapse rate during pregnancy. The prevalence of complications was relatively low, with 4.9% of obstetric and 1.4% neonatal unfavorable outcomes. CONCLUSIONS: Our patients had low degrees of disability, short histories of disease, high drug exposure, and relatively high relapse rate in the year previous to pregnancy. Obstetric and neonatal outcomes were successful in over 90% of our patients.


Subject(s)
Multiple Sclerosis/epidemiology , Pregnancy Complications/epidemiology , Adolescent , Adult , Birth Weight/drug effects , Brazil/epidemiology , Data Interpretation, Statistical , Databases, Factual , Female , Glatiramer Acetate , Humans , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Interferon Type I/adverse effects , Interferon Type I/therapeutic use , Multiple Sclerosis/drug therapy , Peptides/adverse effects , Peptides/therapeutic use , Pregnancy , Pregnancy Outcome , Recombinant Proteins , Recurrence , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...